Please login to the form below

Not currently logged in
Email:
Password:

DynaVax

This page shows the latest DynaVax news and features for those working in and with pharma, biotech and healthcare.

Dynavax is ‘deal-ready’ after solid ESMO data; analyst

Dynavax is ‘deal-ready’ after solid ESMO data; analyst

Contrasting results for two novel immunotherapies. New data for Dynavax Technologies’ SD-101 suggest it could have an edge among new drugs that aim to stimulate immune responses in the tumour ... in development give Dynavax a stronger competitive edge

Latest news

  • Dynavax receives FDA green light for hepatitis B vaccine Dynavax receives FDA green light for hepatitis B vaccine

    Dynavax is celebrating some positive news after it received a US marketing licence for its hepatitis B prevention vaccine, its first FDA-approved product. ... Dynavax expects to launch its vaccine in the US in the first quarter of 2018.

  • FDA gives priority review for Keytruda in lung cancer FDA gives priority review for Keytruda in lung cancer

    A just-signed agreement with Dynavax will see Keytruda and another Merck compound - anti-interleukin-10 drug MK-1966 - tested alongside Dynavax' SD-101, a toll-like receptor 9 (TLR9) agonist

  • Kane & Finkel closes Kane & Finkel closes

    The agency was hit first when the FDA denied approval of Dynavax Technologies' adult hepatitis B vaccine Heplisav.

  • FDA approves Sanofi's four-in-one flu vaccine FDA approves Sanofi's four-in-one flu vaccine

    According to Dynavax, the FDA informed the company “that to do so would unnecessarily restrict the patient population that could benefit from Heplisav's approval”. ... Eddie Gray, CEO of Dynavax, said the company appreciated “the informative

  • Dynavax and Merck & Co team up for phase III Hep B vaccine

    Dynavax will continue to manage ongoing phase III studies in Canada and the EU, as well as other licensure-required studies. ... Production of the vaccine will be expanded at a new facility to support expected market needs, according to Dynavax.

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Pfizer veteran joins Dynavax board Pfizer veteran joins Dynavax board

    Natale Ricciardi spent 39 years at pharma giant. Natale Ricciardi has joined the board of Dynavax Technologies two years after retiring from Pfizer. ... On behalf of Dynavax, we are delighted to welcome Nat to the board,” said Arnold Oronsky, chairman

  • David Novack leaves Novartis for Dynavax David Novack leaves Novartis for Dynavax

    Vaccines-focused biopharma Dynavax has appointed David Novack, formerly of Novartis, to be its senior VP of operations and quality. ... In addition to Novack's appointment, Dynavax also announced that Stephen Tuck, VP, global technical operations is to

  • Andrew Gengos joins ImmunoCellular as CEO Andrew Gengos joins ImmunoCellular as CEO

    He has also spent time at Dynavax Technologies, Chiron Corporation and McKinsey &Company.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics